Advertisement

News from ESC 2013

Feature |
September 4, 2013

News from ESC 2013

NEJM Journal Watch Cardiology and CardioExchange coverage of the meeting

This week, NEJM Journal Watch Cardiology and CardioExchange, an online forum for cardiology news and discussion, have brought you coverage of study findings presented at the European Society of Cardiology 2013 Meeting in Amsterdam. A rundown of that coverage follows:

Hokusai-VTE: Edoxaban versus warfarin in patients with VTE/PE

TASTE: Thrombus aspiration during STEMI treatment

RE-ALIGN: Dabigatran in patients with mechanical heart valves

ICAP: Colchicine for acute pericarditis

PRAMI: Preventive angioplasty in nonculprit lesions during primary PCI

ACCOAST: Pretreatment with prasugrel before PCI

IN-TIME: Wireless home monitoring of patients with heart failure

EXAMINE: Cardiovascular outcomes with alogliptin

SAVOR: Cardiovascular outcomes with saxagliptin

COMPARE: Losartan for Marfan syndrome

Mortality in French participants in the Tour de France

EchoCRT: CRT in patients with narrow QRS and echocardiographic dyssynchrony

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement